tiprankstipranks
Advertisement
Advertisement

AU:PTX Stock Latest News

Prescient Therapeutics Cleans Up Capital Structure as 4 Million Options Expire
Company AnnouncementsPrescient Therapeutics Cleans Up Capital Structure as 4 Million Options Expire
11d ago
PTX
Prescient Tightens Governance With Updated Securities Trading Policy
PremiumCompany Announcements
Prescient Tightens Governance With Updated Securities Trading Policy
5M ago
PTX
Prescient widens half-year loss as R&D spend climbs but bolsters balance sheet
PremiumCompany Announcements
Prescient widens half-year loss as R&D spend climbs but bolsters balance sheet
5M ago
PTX
Prescient Wins EU Orphan Status for PTX‑100, Advances Global CTCL Trial and Cell Therapy Platforms
PremiumCompany Announcements
Prescient Wins EU Orphan Status for PTX‑100, Advances Global CTCL Trial and Cell Therapy Platforms
6M ago
PTX
Prescient Therapeutics Issues 21.78m Unquoted Options Under Employee Incentive Plan
PremiumCompany Announcements
Prescient Therapeutics Issues 21.78m Unquoted Options Under Employee Incentive Plan
7M ago
PTX
Prescient Therapeutics Gains EU Approval for PTX-100 CTCL Trial
PremiumCompany AnnouncementsPrescient Therapeutics Gains EU Approval for PTX-100 CTCL Trial
7M ago
PTX
Prescient Therapeutics Announces Director’s Interest Change
Premium
Company Announcements
Prescient Therapeutics Announces Director’s Interest Change
8M ago
PTX
Prescient Therapeutics Announces Director’s Change in Securities Interest
Premium
Company Announcements
Prescient Therapeutics Announces Director’s Change in Securities Interest
8M ago
PTX
Director’s Interest Update at Prescient Therapeutics
PremiumCompany Announcements
Director’s Interest Update at Prescient Therapeutics
8M ago
PTX
Prescient Therapeutics Announces Director’s Acquisition of Options
PremiumCompany Announcements
Prescient Therapeutics Announces Director’s Acquisition of Options
8M ago
PTX
Prescient Therapeutics Director Acquires New Options
PremiumCompany Announcements
Prescient Therapeutics Director Acquires New Options
8M ago
PTX
Prescient Therapeutics Gains EU Orphan Drug Designation for PTX-100
PremiumCompany Announcements
Prescient Therapeutics Gains EU Orphan Drug Designation for PTX-100
8M ago
PTX
Prescient Therapeutics Issues New Employee Incentive Options
PremiumCompany AnnouncementsPrescient Therapeutics Issues New Employee Incentive Options
8M ago
PTX
Prescient Therapeutics Amends Constitution to Support Strategic Goals
Premium
Company Announcements
Prescient Therapeutics Amends Constitution to Support Strategic Goals
9M ago
PTX
Prescient Therapeutics Advances PTX-100 Study for CTCL Treatment
Premium
Company Announcements
Prescient Therapeutics Advances PTX-100 Study for CTCL Treatment
9M ago
PTX
Prescient Therapeutics Advances PTX-100 with Strategic Milestones
PremiumCompany Announcements
Prescient Therapeutics Advances PTX-100 with Strategic Milestones
9M ago
PTX
Prescient Therapeutics Bolsters Cash Reserves and Advances Cancer Therapy Trials
PremiumCompany Announcements
Prescient Therapeutics Bolsters Cash Reserves and Advances Cancer Therapy Trials
9M ago
PTX
Prescient Therapeutics Announces Hybrid Annual General Meeting
PremiumCompany Announcements
Prescient Therapeutics Announces Hybrid Annual General Meeting
10M ago
PTX
Prescient Therapeutics Issues New Unquoted Equity Securities
PremiumCompany Announcements
Prescient Therapeutics Issues New Unquoted Equity Securities
11M ago
PTX
Prescient Therapeutics Completes $3 Million Share Placement to Advance Cancer Therapies
PremiumCompany AnnouncementsPrescient Therapeutics Completes $3 Million Share Placement to Advance Cancer Therapies
11M ago
PTX
Prescient Therapeutics Lists New Securities on ASX
Premium
Company Announcements
Prescient Therapeutics Lists New Securities on ASX
11M ago
PTX
Prescient Therapeutics Releases Corporate Governance Statement
Premium
Company Announcements
Prescient Therapeutics Releases Corporate Governance Statement
11M ago
PTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >